Efavirenz and Renal function test abnormal - a phase IV clinical study of FDA data

Summary:

Renal function test abnormal is reported as a side effect among people who take Efavirenz (efavirenz), especially for people who are female, 50-59 old, have been taking the drug for < 1 month also take Emtricitabine, and have Immunodeficiency disorders.

The phase IV clinical study analyzes which people have Renal function test abnormal when taking Efavirenz. It is created by eHealthMe based on reports of 15,449 people who have side effects when taking Efavirenz from the FDA, and is updated regularly.

What is Efavirenz?

Efavirenz has active ingredients of efavirenz. It is often used in hiv infection. eHealthMe is studying from 15,501 Efavirenz users. Check the latest studies of Efavirenz.

What is Renal function test abnormal?

Renal function test abnormal is found to be associated with 497 drugs and 566 conditions by eHealthMe. Check the latest studies of Renal function test abnormal.

On Jul, 15, 2026

15,449 people reported to have side effects when taking Efavirenz.
Among them, 12 people (0.08%) have Renal function test abnormal.

Could Efavirenz cause Renal function test abnormal?

Among these 12 people:

How long have people been on Efavirenz when they have Renal function test abnormal? *

What is the gender of people who have Renal function test abnormal when taking Efavirenz? *

female: 55.56 %
male: 44.44 %

What is the age of people who have Renal function test abnormal when taking Efavirenz? *

What are other drugs people take besides Efavirenz? *

Dovato: 4 people, 33.33%
Emtricitabine: 4 people, 33.33%
Tenofovir Disoproxil Fumarate: 2 people, 16.67%
Viread: 1 person, 8.33%
Fluorouracil: 1 person, 8.33%
Atazanavir Sulfate: 1 person, 8.33%
Cisplatin: 1 person, 8.33%
Clarithromycin: 1 person, 8.33%
Exjade: 1 person, 8.33%
Kaletra: 1 person, 8.33%

What are other side effects people have besides Renal function test abnormal? *

Enlarged Prostate: 4 people, 33.33%
Lipids Increased (excess lipid in body): 4 people, 33.33%
High Blood Pressure: 4 people, 33.33%
Urinary Retention (the inability to completely or partially empty the bladder): 4 people, 33.33%
Blood Alkaline Phosphatase Increased: 1 person, 8.33%
High Blood Cholesterol: 1 person, 8.33%
Head Discomfort: 1 person, 8.33%
Haemarthrosis (haemarthrosis is where blood is able to enter the joint capsule): 1 person, 8.33%
Gamma-Glutamyltransferase Increased: 1 person, 8.33%
Fever: 1 person, 8.33%

What are the existing conditions these people have? *

Rectal Cancer (cancer of rectum): 1 person, 8.33%
Insomnia (sleeplessness): 1 person, 8.33%
Immunodeficiency Disorders: 1 person, 8.33%

* Approximation only. Some reports may have incomplete information.

Do you take Efavirenz and have Renal function test abnormal?

- Check whether Renal function test abnormal is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Efavirenz:

Efavirenz (15,501 reports)

Browse all side effects of Efavirenz:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Renal function test abnormal:

Renal function test abnormal (498 drugs)

Browse all the conditions that are associated with Renal function test abnormal:

Renal function test abnormal (566 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on efavirenz (the active ingredients of Efavirenz) and Efavirenz (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.